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Abstract
Background: Symptomatic respiratory tract involvement is not common in Crohn's disease.
Upper-airway obstruction has been reported before in Crohn's disease and usually responds well
to steroid treatment.
Case presentation: We report a case of a 32-year old patient with Crohn's disease who
presented with progressively worsening dyspnea on exertion. Magnetic Resonance Imaging of the
chest and bronchoscopy revealed severe tracheal stenosis and marked inflammation of tracheal
mucosa. Histopathology of the lesion showed acute and chronic inflammation and extended
ulceration of bronchial mucosa, without granulomas. Tracheal stenosis was attributed to Crohn's
disease after exclusion of other possible causes and oral and inhaled steroids were administered.
Despite steroid treatment, tracheal stenosis persisted and only mild symptomatic improvement
was noted after 8 months of therapy. The patient subsequently underwent rigid bronchoscopy with
successful dilatation and ablation of the stenosed areas and remission of her symptoms.
Conclusion:  Respiratory involvement in Crohn's disease might be more common than
appreciated. Interventional pulmonology techniques should be considered in cases of tracheal
stenosis due to Crohn's disease refractory to steroid treatment.
Background
Crohn's disease (CD) is a nonspecific chronic inflamma-
tory disease that most commonly affects the distal ileum
and colon and occasionally exhibits extra-intestinal man-
ifestations. Symptomatic respiratory tract involvement is
not common, pulmonary lesions, however, have been
reported in CD, including chronic bronchitis [1], bron-
chiectasis [1,2], upper-airway obstruction [3-7], bronchi-
olitis obliterans organizing pneumonia [1],
granulomatous lung disease [1,8,9] and interstitial lung
disease [10]. This report describes a young patient with
CD who developed severe tracheal stenosis.
Case presentation
A 32-yr old Caucasian female patient presented in Sep-
tember 2004 with progressively worsening dyspnea on
exertion. Since 2002, she had suffered from typical CD
with arthritis, which had been diagnosed on clinical,
endoscopic and histological grounds. She had undergone
colonoscopy and biopsy in order to investigate symptoms
of persistent diarrhea with abdominal pain, weight loss
Published: 07 April 2006
BMC Pulmonary Medicine2006, 6:7 doi:10.1186/1471-2466-6-7
Received: 03 January 2006
Accepted: 07 April 2006
This article is available from: http://www.biomedcentral.com/1471-2466/6/7
© 2006Plataki et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Pulmonary Medicine 2006, 6:7 http://www.biomedcentral.com/1471-2466/6/7
Page 2 of 5
(page number not for citation purposes)
and fever. Colonoscopy had revealed mucosal ulcerations
involving the distal ileum and right colon alternating with
areas of normal-appearing mucosa and histological exam-
ination had shown transmural inflammation and epithe-
lioid granulomas, typical of CD. In the following years,
her gastrointestinal symptoms were well-controlled on
sulphasalazine 3000 mg·day-1, azathioprine 100 mg·day-
1 and folic acid 5 mg·day-1 and she experienced no exacer-
bations. Over the past year she has suffered from recurrent
episodes of acute bronchitis. She has been repeatedly
treated with antibiotics and short courses of oral steroids,
followed by improvement of symptoms of infection
(cough and sputum production). She complained, how-
ever, of progressive deterioration of her dyspnea and was
referred by her family doctor to the Thoracic Department
of the University Hospital of Heraklion for further evalu-
ation and treatment.
On presentation, severe dyspnea on exertion subsiding at
rest was noted. On physical examination, the patient was
tachypnoeic and had stridor, reduced breath sounds and
diffuse wheezing on auscultation. She was a lifelong non-
smoker and had no history of occupational or environ-
mental exposure relevant to lung disease. Her temperature
was 36.6°C and her arterial oxygen saturation at rest was
97% (room air). Post exertion arterial blood-gas analysis
did not reveal hypoxemia (alveolar-arterial oxygen ten-
sion gradient at peak exercise was 10 mmHg). The electro-
cardiogram and chest radiographs were normal.
Laboratory investigations showed normal serum values of
electrolytes, glucose, protein, liver function tests, urea and
creatinine. Other laboratory tests showed a moderately
increased erythrocyte sedimentation rate of 31 mm·1 h-1,
and normal C-reactive protein (< 0.32 mg/dl). Complete
blood count revealed mildly elevated white blood cell
count (12.3 K·µl-1, 90.8% neutrophils). Assessments of
anti-nuclear antibodies, anti-DNA antibodies, anti-neu-
trophil cytoplasmic antibodies (ANCA, both cytoplasmic-
and perinuclear-ANCA), and serum angiotensin-convert-
ing enzyme (sACE) were normal. Serologic tests for Myc-
oplasma pneumoniae, Chlamydia pneumoniae,
respiratory syncytial virus, adenovirus, and influenza
viruses were all negative. Tuberculin skin test was nega-
tive. Sputum cultures for mycobacteria and fungi were
negative. Pulmonary function tests showed airway
obstruction (Table 1) and flow-volume curve intra-
extrathoracic airway obstruction. There was no improve-
ment in forced expiratory volume in one second (FEV1)
following inhalation of β2-agonist. Magnetic resonance
imaging (MRI) of the trachea revealed a 2-cm region of
severe subglottic tracheal stenosis with marked increase in
tracheal wall thickness (Figure 1). High resolution com-
puted tomography scan (HRCT) of the thorax did not
show any abnormalities.
Table 1: Sequential evaluation of pulmonary function tests.
Parameter September 2004 October 2004 December 2004 February 2005 July 2005
FVC 3.47 (102) 3.59 (106) 3.56 (106) 3.71 (107.5) 3.88 (112.3)
FEV1 1.28 (43.5) 1.6 (54.3) 2.76 (94.5) 3.19 (106.5) 3.39 (113)
FEV1/FVC% 36.9 44.5 77.6 86.05 87.42
FEF25–75 L/s 1.13 (29.2) 1.41 (36.4) 2.72 (71.1) 3.51 (91.1) 4.00 (103.7)
Data in parentheses are percentage of predicted value. Measurements in September 2004 were taken on admission; those in October 2004 and 
December 2004 were after 4 weeks and 12 weeks of oral and inhaled steroids, respectively; those in February 2005 were after 20 weeks of 
therapy; and those in July 2005 after bronchoscopic dilatation and 40 weeks of therapy. FVC: forced vital capacity; FEV1: forced expiratory volume 
in one second; FEF25–75: forced mid-expiratory flow.
Magnetic Resonance Imaging (MRI) Figure 1
Magnetic Resonance Imaging (MRI). MRI_axial: (A) Axial T1-
weighted Spin Echo (SE) MRI shows circumferential thicken-
ing of the trachea (white arrow) with intermediate signal 
intensity of the thickened mucosa/submucosa. (B) T2-
weighted Turbo SE MRI at the same level. Note the patho-
logical high signal intensity of the thickened mucosa/submu-
cosa, which corresponds to mucosal inflammation. MRI_sag: 
(C) Sagittal T1-weighted SE MRI shows irregular narrowing 
of the airway (white arrow). (D) Sagittal T2-weighted Turbo 
SE MRI of the subglottic trachea shows thickening of the tra-
cheal lumen with high signal intensity due to inflammation.BMC Pulmonary Medicine 2006, 6:7 http://www.biomedcentral.com/1471-2466/6/7
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A fiberoptic bronchoscopy (FOB) was performed, and
showed severe circumferential tracheal stenosis, greater
than 70%, 1–2 cm beneath the vocal cords and marked
inflammation of tracheal mucosa (Figure 2A). The patient
did not tolerate penetration of the bronchoscope through
the obstruction. Bacteriologic studies of bronchial wash-
ings, including cultures for mycobacteria and fungi, were
negative. Cytologic studies of bronchial washings showed
inflammatory cells and no malignant cells. Histological
examination of several biopsies of the stenosed areas
revealed acute and chronic inflammation and extended
ulceration of bronchial mucosa, without granulomas (Fig-
ure 2B).
The patient received inhaled budesonide 800 µg·day-1
and methylprednisolone 120 mg·day-1 iv for 5 days. Then
she continued on oral methylprednisolone 24 mg·day-1
and inhaled budesonide 800 µg·day-1. During the follow-
ing months she reported improvement of her shortness of
breath, accompanied by gradual improvement of her lung
function tests (Table 1). In May 2005 she was referred to
the Complex Airway Center of the Beth Israel Deaconess
Medical Center for further evaluation.
On presentation in the Complex Airway Center, her throat
on auscultation revealed mild inspiratory stridor. There
was otherwise no wheezing, chest exam was normal, as
was the remainder of her examination, and room air oxy-
genation was 99%. A specialized airway CT was per-
formed, which demonstrated a 2-cm region of
circumferential subglottic stenosis with focal narrowing
that did not spare the membranous portion of the trachea
(Figure 3). The remainder of the trachea appeared unre-
markable without evidence of tracheobronchomalacia.
There were regions of patchy ground glass opacity in the
superior segment of the right middle lobe, with some cen-
trilobular nodular opacities and patchy opacities in the
right lower lobe superior segment with air trapping.
At flexible bronchoscopy a high-grade subglottic obstruc-
tion was visible at about 7 or 8 mm diameter opening. The
obstruction was complex, reaching from the posterior
subglottic area close to the vocal cords and posterior ary-
tenoids all the way down to the cricoid ring in a circular
fashion. Rigid bronchoscopy confirmed the subglottic ste-
nosis and showed that it extended into the first tracheal
ring. The area was biopsied, dilated sequentially to 12 mm
and the remaining tissues were cleanly ablated with the
help of a microdebrider. The diameter achieved in the end
was approximately 14 mm and appeared normal for her
size. Five cc of 0.04% mitomycin-C was also applied for
four minutes. During the rigid bronchoscopy several addi-
tional abnormalities were visualized. The left upper lobe
was near-totally occluded by a web-like obstruction,
which was also biopsied and dilated. Moreover, the right
medial segment of the right lower lobe was near-totally
occluded with what appeared to be mucosal and submu-
cosal swelling, which was again extensively biopsied and
a lumen was reestablished. The pathology results revealed
partially ulcerated respiratory mucosa with squamous
metaplasia, lamina propria fibrosis, recent hemorrhages
and acute and chronic inflammation in all three locations,
but no granulomas.
This treatment led to complete remission of the patient's
respiratory symptoms up to the point that this report is
written, 10 months after dilatation. She continued treat-
ment with oral methylprednisolone 24 mg·day-1, inhaled
budesonide 800 µg·day-1  and oral omeprazole 20
mg·day-1. The patient will be closely followed with pul-
monary function tests and endoscopic approaches, if nec-
essary, and progressive tapering of oral steroid treatment
over the following months will be attempted.
Conclusion
The authors report a case of a young female with CD, who
developed tracheal inflammation and stenosis that
improved but persisted, despite corticosteroid treatment.
Although the lungs are not a common site of involve-
ment, pulmonary lesions have been reported in CD.
Latent pulmonary involvement might be more frequent
than considered and subclicinal abnormalities, like
increased bronchial hyperresponsiveness [11,12],
impairement of lung function parameters [13,14],
Fiberoptic bronchoscopy and histological examination of tra- cheal stenosis Figure 2
Fiberoptic bronchoscopy and histological examination of tra-
cheal stenosis. (A) Circumferential tracheal stenosis, greater 
than 70%, 1–2 cm beneath the vocal cords and marked 
inflammation of tracheal mucosa was noted at fiberoptic 
bronchoscopy. (B) Histological examination revealed acute 
and chronic inflammation and extended ulceration of bron-
chial mucosa, without granulomas.BMC Pulmonary Medicine 2006, 6:7 http://www.biomedcentral.com/1471-2466/6/7
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increased lymphocyte numbers in bronchoalveolar lavage
and induced sputum [15,16] and increase of lung perme-
ability [17], have been well-described.
In the present case, other disease processes that might
cause a similar picture had to be excluded. Tuberculous
stenosis is an endobronchial complication of pulmonary
tuberculosis. In this patient, mycobacterial infection
could be excluded by the absence of caseating granulo-
mas, negative tuberculin skin test, and failure to identify
mycobacteria on culture. Sarcoidosis and CD share path-
ologic and immunologic features [18]. In this case, there
was little evidence in favor of sarcoidosis: there was no
extrapulmonary sarcoid involvement, no mediastinal
lymph node involvement, sACE level was normal and typ-
ical sarcoid granulomata in bronchial biopsies were
absent. Moreover, the absence of histological findings
suggestive of Wegener's granulomatosis, the lack of cyto-
plasmic-ANCA and no extrapulmonary involvement,
made the diagnosis of Wegener's granulomatosis unlikely.
Relapsing polychondritis was excluded on the basis of
clinical, radiological and histological criteria.
Tracheobronchial involvement is rare in CD, but has been
reported before [1-9,19]. Mucosal inflammation of the
trachea and bronchi may be observed, with or without
upper airway stenosis, in any age group. Histologically,
there may be airway infiltration by inflammatory cells and
mucosal ulceration, but non-caseating granulomas are
not always present [1,8]. The diagnosis of CD usually pre-
cedes the presentation of pulmonary manifestations, but
previously undiagnosed CD presenting with airway man-
ifestations has also been reported [4]. Symptoms of tra-
cheobronchial involvement usually respond well to
appropriate doses of inhaled and/or systemic steroids. In
the present case, however, although the patient reported
improvement with steroid treatment, she still complained
of symptoms compromising her quality of life, making a
more invasive approach necessary. Bronchoscopic dilata-
tion led to complete remission of her symptoms. Stent
placement was not feasible as the lesion was in the glottic
and subglottic space involving the vocal cords. The lesions
were not approachable surgically as they were multifocal
and still revealed chronic inflammation. Surgery could be
indicated at a later point when the inflammation has
turned into fibrosis. Aggressive treatment with inhaled
and oral steroids is still necessary for this patient to avoid
relapse, since inflammation is an ongoing process.
In summary, this is a report of a patient with CD who
developed severe airway obstruction, despite the fact that
gastrointestinal symptoms were well-controlled on con-
ventional CD treatment. Systemic and inhaled steroid
treatment led to some improvement, in agreement with
previous reports of the effectiveness of steroid administra-
tion in similar cases [1]. In this case however, mucosal
inflammation and symptoms persisted, making a more
invasive approach necessary. Interventional pulmonary
medicine has made great progress during recent years,
proving to be a valuable tool for respiratory physicians. To
our knowledge this is the first report of a patient with tra-
cheal stenosis from CD successfully treated with rigid
bronchoscopy and dilatation. Respiratory involvement in
CD might be more common than appreciated and the
need exists for early diagnosis and appropriate treatment
of airway complications, which might otherwise prove to
be life-threatening.
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Computed Tomography (CT) Figure 3
Computed Tomography (CT). (A) CT_ volume rendering 
technique (VRT): The VRT of the tracheobronchial tree, 
clearly demonstrates the segment of irregular stenosis of the 
subglottic trachea (white arrow). (B) CT _axial: CT scan 
shows marked circumferential narrowing of the subglottic 
part of the trachea. No calcification can be seen. (C and D) 
CT_sag_multi planar reconstruction (MPR): On (C) end-
expiration and (D) end-inspiration sagittal MPR of CT scan, a 
dynamic collapse of the trachea can not be documented.Publish with BioMed Central    and   every 
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